BN
Broadstone Net Lease, Inc. (BNL)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 revenue was $112.99M and GAAP diluted EPS was $0.10, while AFFO per share was $0.38; management raised FY2025 AFFO guidance to $1.48–$1.50 per share at mid-point 4.2% growth .
- Against Wall Street consensus, revenue was a modest beat, but GAAP EPS was a miss; revenue beat vs ~$110.68M consensus and EPS missed vs ~$0.18 consensus. Values retrieved from S&P Global.*
- Operational execution remained strong: 99.1% occupancy, 99.6% rent collection (+60bps YoY), and $140.8M invested in Q2 with industrial-focused deployment and an 8.3% straight-line yield on acquisitions .
- Balance sheet capacity intact (>$800M revolver availability), though leverage ticked up to 5.3x Net Debt/Annualized Adjusted EBITDAre; CFO reduced the bad debt reserve to 75bps for the remainder of 2025 given progress on tenant matters .
- Catalyst: a differentiated build-to-suit pipeline (~$371M committed) expected to add ~$28M ABR through 2026 (~6.9% ABR growth), plus raised 2025 investment volume guidance ($500–$700M) .
What Went Well and What Went Wrong
What Went Well
- Raised FY2025 AFFO guidance to $1.48–$1.50 per share (midpoint +4.2% YoY), citing strong YTD performance, tenant resolutions, and accretive investments; “steadfast commitment to delivering long-term, sustainable growth” (CEO) .
- Investment program momentum: $140.8M invested in Q2 (industrial-weighted), with Q2 acquisitions at 7.1% initial cash cap and 8.2% straight-line yield; YTD investments $229.1M with 8.3% straight-line yield on acquisitions .
- Portfolio health strengthened: 99.1% leased, 99.6% rent collection (+60 bps YoY), diversified tenant base (no tenant >4% ABR), and ABR WALT 9.7 years; clinical & surgical exposure reduced to 2.4% of ABR via dispositions .
What Went Wrong
- GAAP net income declined 44.8% YoY to $19.8M ($0.10 diluted EPS) due to higher impairment provision (+$8.1M vs prior year), creating a headline EPS miss versus consensus .
- Leverage increased: Net Debt to Annualized Adjusted EBITDAre rose to 5.3x (Pro Forma 5.2x) from 5.1x in Q1; modest deleveraging deferred amid funding of committed growth .
- FX volatility: ~$3.4M unrealized FX loss affected Core FFO adjustments; continued macro/tariff pressures and consumer-centric tenant risk pockets monitored by management .
Financial Results
Actuals vs Consensus (Q2 2025)
Values retrieved from S&P Global.*
Segment Breakdown (Q2 2025, ABR-based)
Key KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “We are raising our full-year guidance to $1.48 to $1.50 AFFO per share, or 4.2% growth at our midpoint… our steadfast commitment to delivering long-term, sustainable growth” .
- CEO on tenant credit: At Home (~95 bps ABR) and Claire’s (~80 bps ABR) rents are current; strategic assets with below-market rents provide optionality; confident in outcomes .
- CFO: Reduced bad debt reserve for remainder of year to 75bps given progress; ended quarter with >$800M revolver availability and ~5.2x pro forma leverage .
- President/COO: Build-to-suit program scaling across six developers; committed pipeline to deliver ~$28M ABR by 2026; target 100bps+ spread between development yield and stabilized value .
Q&A Highlights
- Build-to-suit goal reaffirmed: Management still targets ~$500M incremental build-to-suit commitments in 2025; pipeline broadened by referrals and developer relationships; expect deals to stabilize 2026–2027 .
- Regular-way acquisitions under control: ~$234.6M, primarily industrial, with cap rates ~7%, closing mostly in Q3/Q4 2025; competition fierce among private buyers .
- Leverage philosophy: Comfortable flexing near term but aim to remain “comfortably inside 6x” over time; deleveraging as projects stabilize .
- Pricing mechanics and escalators: New industrial escalators ~2.5–3%; risk mitigants via GMP/lump-sum contracts, contingencies, change orders to handle tariff/cost volatility .
- Capital strategy: Equity unattractive at current yield; retain self-funded growth options through dispositions and build-to-suit monetization at ~100bps better stabilized valuations .
Estimates Context
- Q2 2025 actual vs S&P Global consensus: Revenue $112.99M vs $110.68M consensus (Beat); GAAP EPS $0.10 vs $0.18 consensus (Miss). Values retrieved from S&P Global.*
- Implication: Given raised FY2025 AFFO guidance and stronger top-line/NOI, sell-side may lift revenue/AFFO forecasts while trimming near-term GAAP EPS assumptions due to non-cash impairment and FX noise; build-to-suit visibility supports 2026–2027 mid-single-digit AFFO per share growth .
Key Takeaways for Investors
- Industrial-led growth strategy is gaining traction: committed build-to-suits add ~$28M ABR through 2026, supporting mid-single-digit AFFO/share growth through 2026–2027 .
- Expect continued internal funding of growth: leverage temporarily higher (~5.3x) but ample liquidity; management prefers recycling/monetization over dilutive equity at current valuation .
- Tenants under watch are manageable: At Home and Claire’s are current on rent, assets are strategic with below-market rents; bad debt reserve lowered, reducing downside risk to 2025 AFFO .
- Trading lens: Near-term stock catalysts include ongoing acquisitions closes (~$234.6M under control), build-to-suit announcements, and Investor Day (Dec 2) providing 2026 preliminary guidance; expect the market to reward visibility of embedded growth .
- Medium-term thesis: Industrial mix (60.7% ABR) and rising escalators (2.5–3% on new industrial deals) enhance organic growth; disciplined underwriting and diversified tenants mitigate idiosyncratic risk .
- Watch leverage trajectory and FX: As projects stabilize (and potential asset sales occur), leverage should resume downward trend; FX noise may persist but is largely non-operational .
- Dividend stability: $0.29/share quarterly remains intact, supported by resilient AFFO and portfolio metrics .
Note: All consensus values marked with * are from S&P Global and may differ from some publicly available sources due to methodology and rounding.
Citations:
- Q2 2025 results and guidance:
- Investments, portfolio metrics, leverage:
- Build-to-suit pipeline and ABR uplift:
- Q1 2025 prior quarter context:
- Segment/ABR breakdown:
- Q&A details and management commentary:
- 2024 context: